UAE states urged to embrace generic medicines to curb Rx drug costs

16 April 2010

Health authorities in the United Arab Emirates may start encouraging the sale of generic drugs to drive down the cost prescription medications. A senior official at the Abu Dhabi Health Authority Dhabi (HAAD) has called for the introduction of cost-effective drugs across Abu Dhabi through a strategy that does not compromise patient safety.

Speaking to the local newspaper Gulf News at the first annual Middle East Generic Medicine Conference, Mohammad Abu Al Khair, section head of HAAD's Drugs and Medical Products
Regulation Department, said UAE pharmaceutical sales were amongst the highest in the world. The usage of pharmaceutical products in the UAE has grown at a rate of 21% per annum above the world average.

The HAAD is considering tackling the high prices by putting a ceiling on the payments from insurance companies to pharmacies. Insurers pay out 100% of a drug's value when they receive a bill from a pharmacy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics